Thu, Jul 31, 2014, 6:51 PM EDT - U.S. Markets closed


% | $
Click the to save as a favorite.

Cubist Pharmaceuticals Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • davieswatson davieswatson Feb 9, 2012 12:45 PM Flag

    Crappy Stock

    Two things....once CBST files, they will "stay" the applicaiton for the generic. Meaning there is no issue.

    In the agreement with TEVA, TEVA must pretty much buy the drup from CBST, and then resell it....(I just read this today)

    I would only say that I think this is a good, small, short opportunity for shorts to cover some of their looking at the volume, CBST is STILL holding pretty well.

    I guess I am not concerned about the news, but I am sure there will be several weeks of articles written how this WILL materially hurt CBST....buying opportunity is the way I look at it.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Hospira must have read all the legal docs from the Teva suit. Did they conclude that there was something that Teva missed? If not, why are they willing to file a paragraph IV knowing that they will have to spend a couple of million defending the inevitable patent infringement suit?

      Regardless of whether the above has any merit, given the potential downside, will new buyers of CBST stock be willing to step up to the plate? I doubt it.

      To assert that CBST is a strong buy here, after the strong advance over the last year, fails my risk/reward analysis. JMO.

60.90-0.76(-1.23%)Jul 31 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.